| OPKO HEALTH INC. DL-,01 |
| USA |
| Gesundheit |
| US68375N1037 / A0MUUJ |
| XCY (Frankfurt) / OPK (NASDAQ) |
| FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK |
| - |
| https://www.opko.com/ |
|
OPKO Health, Inc. is a diversified healthcare company focused on diagnostics and pharmaceuticals. Through its Diagnostics segment, the company provides clinical laboratory and genetic testing services, including BioReference Health and specialized as..
>Volltext.. |
| 1085.19 Mio. EUR |
| 1170.34 Mio. EUR |
| 511.87 Mio. EUR |
| -68.06 Mio. EUR |
| -63.46 Mio. EUR |
| -0.08 EUR |
| 346.6 Mio. EUR |
| 261.87 Mio. EUR |
| -107.42 Mio. EUR |
| 2.01 |
| -8.67% |
| 57.56% |
| - |
| - |
| - |
| - |
| OPKO HEALTH |
| 19.09.26 |